55818 Federal Register / Vol. 62, No. 208 / Tuesday, October 28, 1997 / Notices

Clifton Road, NE., Atlanta, Georgia

30333, telephone (404) 639–6322.

SUPPLEMENTARY INFORMATION: These

toxicological profiles were developed by

ATSDR for hazardous substances at

Department of Energy (DOE) waste sites

under Section 104(i) (3) and (5) of the

Comprehensive Environmental

Response, Compensation, and Liability

Act of 1980 (CERCLA or Superfund).

This public law directed ATSDR to

prepare toxicological profiles for

hazardous substances most commonly

found at facilities on the CERCLA

National Priorities List (NPL) and that

pose the most significant potential

threat to human health, as determined

by ATSDR and the EPA. The current

ATSDR priority list of hazardous

substances at DOE NPL sites was

announced in the Federal Register on

July 24, 1996 (61 FR 38451).

Although key studies for each of the

substances were considered during the

profile development process, this

Federal Register notice seeks to solicit

any additional studies, particularly

unpublished data and ongoing studies,

which will be evaluated for possible

addition to the profiles now or in the

future.

The following draft toxicological

profiles will be made available to the

public on or about October 17, 1997.

DocumentHazardous substance CAS No.

1. .......... URANIUM ............. Multiple

URANIUM 235 ...... 15117–96–1

URANIUM

HEXAFLUORIDE.

7783–81–5

URANIUM METAL 7440–61–1

URANIUM ORE .... 53125–22–7

URANIUM

OCTAOXIDE.

1344–59–8

URANIUM PEROXIDE.19525–15–6

URANIUM TETRACHLORIDE.10026–10–5

URANIUM TETRAFLUORIDE.10049–14–6

URANYL ACETATE.541–09–3

URANYL NITRATE 10102–06–4

URANYL NITRATE

HEXAHYDRATE.

13520–83–7

URANYL SULFATE.1314–64–3

2. ...... IONIZING RADIATION.NA

All profiles issued as ‘‘Drafts for

Public Comment’’ represent ATSDR’s

best efforts to provide important

toxicological information on priority

hazardous substances. We are seeking

public comments and additional

information which may be used to

supplement these profiles. ATSDR

remains committed to providing a

public comment period for these

documents as a means to best serve

public health and our clients.

Dated: October 22, 1997.

Georgi Jones,

Director, Office of Policy and External Affairs,

Agency for Toxic Substances and Disease

Registry.

[FR Doc. 97–28475 Filed 10–27–97; 8:45 am]

BILLING CODE 4163–70–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Agency for Toxic Substances and

Disease Registry

[ATSDR–127]

Availability of Draft Toxicological

Profiles

AGENCY: Agency for Toxic Substances

and Disease Registry (ATSDR),

Department of Health and Human

Services (HHS).

ACTION: Notice of availability.

SUMMARY: The Comprehensive

Environmental Response,

Compensation, and Liability Act of 1980

(CERCLA), as amended by the

Superfund Amendments and

Reauthorization Act of 1986 (SARA) (42

U.S.C. 9604(i)(3)) directs the

Administrator of ATSDR to prepare

toxicological profiles of priority

hazardous substances and to revise and

publish each updated toxicological

profile as necessary. This notice

announces the availability of five

updated drafts and three new draft

toxicological profiles, comprising the

10th set of profiles, prepared by ATSDR

for review and comment.

DATES: To ensure consideration,

comments on these draft toxicological

profiles must be received on or before

February 17, 1998. Comments received

after the close of the public comment

period will be considered at the

discretion of ATSDR based upon what

is deemed to be in the best interest of

the general public.

ADDRESSES: Requests for copies of the

draft toxicological profiles or comments

regarding the draft toxicological profiles

should be sent to the attention of Ms.

Loretta Norman, Division of Toxicology,

Agency for Toxic Substances and

Disease Registry, Mailstop E–29, 1600

Clifton Road, NE., Atlanta, Georgia

30333.

Requests for the draft toxicological

profiles must be in writing, and must

specifically identify the hazardous

substance(s) profile(s) that you wish to

receive. ATSDR reserves the right to

provide only one copy of each profile

requested, free of charge. In case of

extended distribution delays, requestors

will be notified.

Written comments and other data

submitted in response to this notice and

the draft toxicological profiles should

bear the docket control number ATSDR–

127. Send one copy of all comments and

three copies of all supporting

documents to the Division of Toxicology

at the above address by the end of the

comment period. Because all public

comments regarding ATSDR

toxicological profiles are available for

public inspection after the profile is

published in final, no confidential

business information should be

submitted in response to this notice.

FOR FURTHER INFORMATION CONTACT: Ms.

Loretta Norman, Division of Toxicology,

Agency for Toxic Substances and

Disease Registry, Mailstop E–29, 1600

Clifton Road, NE., Atlanta, Georgia

30333, telephone (404) 639–6322.

SUPPLEMENTARY INFORMATION: The

Superfund Amendments and

Reauthorization Act (SARA) (Pub. L.

99–499) amends the Comprehensive

Environmental Response,

Compensation, and Liability Act

(CERCLA or Superfund) (42 U.S.C. 9601

et seq.) by establishing certain

responsibilities for the ATSDR and the

Environmental Protection Agency (EPA)

with regard to hazardous substances

which are most commonly found at

facilities on the CERCLA National

Priorities List (NPL). Among these

statutory provisions is that the

Administrator of ATSDR prepare

toxicological profiles for substances

included on the priority lists of

hazardous substances. These lists

identified 275 hazardous substances

that ATSDR and EPA determined pose

the most significant potential threat to

human health. The availability of the

revised priority list of 275 hazardous

substances was announced in the

Federal Register on April 29, 1996 (61

FR 18744 ). For prior versions of the list

of substances see Federal Register

notices dated April 17, 1987 (52 FR

12866); October 20, 1988 (53 FR 41280);

October 26, 1989 (54 FR 43619); October

17, 1990 (55 FR 42067); October 17,

1991 (56 FR 52166); October 28, 1992

(57 FR 48801); and February 28, 1994

(59 FR 9486). CERCLA also requires

ATSDR to assure the initiation of a

research program to fill data needs

associated with the substances.

Section 104(i)(3) of CERCLA (42

U.S.C. 9604(i)(3)) outlines the content of

these profiles. Each profile will include

an examination, summary and
Federal Register / Vol. 62, No. 208 / Tuesday, October 28, 1997 / Notices 55819

interpretation of available toxicological

information and epidemiologic

evaluations. This information and these

data are to be used to ascertain the

levels of significant human exposure for

the substance and the associated health

effects. The profiles must also include a

determination of whether adequate

information on the health effects of each

substance is available or in the process

of development. When adequate

information is not available, ATSDR, in

cooperation with the National

Toxicology Program (NTP), is required

to assure the initiation of research to

determine these health effects.

Although key studies for each of the

substances were considered during the

profile development process, this

Federal Register notice seeks to solicit

any additional studies, particularly

unpublished data and ongoing studies,

which will be evaluated for possible

addition to the profiles now or in the

future.

The following draft toxicological

profiles will be made available to the

public on or about October 17, 1997.

DocumentHazardous substance CAS No.

1. .......... CADMIUM ............ 007440–43–9

CADMIUM CARBONATE.000513–78–0

CADMIUM CHLORIDE.010108–64–2

CADMIUM OXIDE 01306–19–0

CADMIUM SULFATE.010124–36–4

CADMIUM SULFIDE.01306–23–6

2. .......... CHLORODIBENZO-P-DIOXIN.039227–53–7

DICHLORODIBENZO-P-DIOXIN.050585–39–2

HEPTACHLORODIBENZO-PDIOXIN.037871–00–4

HEXACHLORODIBENZO-PDIOXIN.034465–46–8

OCTACHLORODIBENZO-PDIOXIN.003268–87–9

PENTACHLORODIBENZO-PDIOXIN.036088–22–9

TRICHLORODIBENZO-P-DIOXIN.039227–58–2

TETRACHLORODIBENZO-PDIOXIN.041903–57–5

1,2,3,4,6,7,8-

HEPTACHLORODIBENZO-PDIOXIN.

035822–46–9

3. .......... CHLOROPHENOLS.000088–06–2

2,3,5,6-

TETRACHLOROPHENOL.

000935–95–5

DocumentHazardous substance CAS No.

2,4,5-

TRICHLOROPHENOL.

000095–95–4

2,4,6-

TRICHLOROPHENOL.

000088–06–2

2-

CHLOROPHENOL.

000120–83–2

4-Chlorophenol ..... 000095–57–8

2,3,4,5-

TETRACHLOROPHENOL.

004901–51–3

2,3,4,6-

TETRACHLOROPHENOL.

000058–90–2

4. .......... DORMALDEHYDE 000050–00–0

5. .......... HEXACHLOROCYCLOHEXANE.000608–73–1

HEXACHLOROCYCLOHEXANE,

ALPHA-.

000319–84–6

HEXACHLOROCYCLOHEXANE,

BETA-.

000319–85–7

HEXACHLOROCYCLOHEXANE,

DELTA-.

000319–86–8

HEXACHLOROCYCLOHEXANE,

GAMMA-.

000058–89–9

6. .......... HEXACHLOROCYCLOPENTADIENE.000077–47–4

7. .......... MANGANESE ....... 007439–96–5

8. .......... HYDROGEN SULFIDE.007783–06–4

All profiles issued as ‘‘Drafts for

Public Comment’’ represent ATSDR’s

best efforts to provide important

toxicological information on priority

hazardous substances. We are seeking

public comments and additional

information which may be used to

supplement these profiles. ATSDR

remains committed to providing a

public comment period for these

documents as a means to best serve

public health and our clients.

Dated: October 22, 1997.

Georgi Jones,

Director, Office of Policy and External Affairs,

Agency for Toxic Substances and Disease

Registry.

[FR Doc. 97–28476 Filed 10–27–97; 8:45 am]

BILLING CODE 4163–70–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Board of Scientific Counselors,

National Center for Infectious

Diseases: Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following committee

meeting.

Name: Board of Scientific Counselors,

National Center for Infectious Diseases

(NCID).

Times and Dates: 11 a.m.–5:15 p.m.,

December 4, 1997; 8:30 a.m.–2:30 p.m.,

December 5, 1997.

Place: CDC, Auditorium B, 1600 Clifton

Road, NE, Atlanta, Georgia 30333.

Status: Open to the public, limited only by

the space available.

Purpose: The Board of Scientific

Counselors, NCID, provides advice and

guidance to the Director, CDC, and Director,

Page 2 NCID, in the following areas: program

goals and objectives; strategies; program

organization and resources for infectious

disease prevention and control; and program

priorities.

Matters to be Discussed: Agenda items will

include:

1. NCID Update

2. Overview of CDC Emerging Infections

Plan, 1998–2003

3. Charge to the Workgroups

4. Workgroup Sessions:

CDC Plan:

a. Surveillance and Response

b. Applied Research

c. Prevention and Control

d. Infrastructure Bioterrorism Preparedness

5. Workgroup Reports

6. Facilities Update

7. Scientific Updates (Late breakers)

8. Recommendations

Other agenda items include

announcements/introductions; follow-up on

actions recommended by the Board in May

1997; Page 3 and consideration of future

directions, goals, and recommendations.

Agenda items are subject to change as

priorities dictate.

Written comments are welcome and should

be received by the contact person listed

below prior to the opening of the meeting.

Contact Person for More Information:

Diane S. Holley, Office of the Director, NCID,

CDC, Mailstop C–20, 1600 Clifton Road, NE,

Atlanta, Georgia 30333, telephone 404/639-

0078.

Dated: October 22, 1997.

Julia M. Fuller,

Acting Director, Management Analysis and

Services Office, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 97–28480 Filed 10–27–97; 8:45 am]

BILLING CODE 4163–18–P